These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26758951)

  • 1. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
    Ermini L; Post M; Caniggia I
    Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HMG-CoA reductase inhibitors on leptin-induced endothelial cell proliferation, migration, and capillary-like tube formation.
    Burgazli KM; Stein NI; Mericliler M; Parahuleva M; Erdogan A
    Postgrad Med; 2014 May; 126(3):231-8. PubMed ID: 24918807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and protein prenylation in cancer cell biology and therapy.
    Garcia-Ruiz C; Morales A; Fernandez-Checa JC
    Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways.
    Siddals KW; Marshman E; Westwood M; Gibson JM
    J Biol Chem; 2004 Sep; 279(37):38353-9. PubMed ID: 15247258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
    Muller AL; Freed DH
    Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mevalonate-suppressive dietary isoprenoids for bone health.
    Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
    J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway.
    Rauthan M; Ranji P; Aguilera Pradenas N; Pitot C; Pilon M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5981-6. PubMed ID: 23530189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
    Thurnher M; Nussbaumer O; Gruenbacher G
    Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review.
    Esteve-Valverde E; Ferrer-Oliveras R; Gil-Aliberas N; Baraldès-Farré A; Llurba E; Alijotas-Reig J
    Obstet Gynecol Surv; 2018 Jan; 73(1):40-55. PubMed ID: 29368790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
    Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J
    Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Mevalonate Pathway in Cancer.
    Juarez D; Fruman DA
    Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
    Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
    Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of statins on the vascular tissue.
    Ikeda U; Shimada K
    Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids.
    Lasunción MA; Martínez-Botas J; Martín-Sánchez C; Busto R; Gómez-Coronado D
    Biochem Pharmacol; 2022 Feb; 196():114623. PubMed ID: 34052188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anticancer properties of statins].
    Sławińska A; Kandefer-Szerszeń M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of statins on preeclampsia: A systematic review.
    Vahedian-Azimi A; Karimi L; Reiner Ž; Makvandi S; Sahebkar A
    Pregnancy Hypertens; 2021 Mar; 23():123-130. PubMed ID: 33333432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.